RxDoctor Payments Data

Cyrus Khorrami, MD

Diagnostic Radiology · Toms River, NJNPI 1902079262

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by SK Life Science, Inc. at 41.2% of the total. Reporting peaked in 2024 at $125 and has fallen 52.2% since, to $60 in 2025.

$303in general payments, 2019–2025

Across 6 payments — averaging $50.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • SK Life Science, Inc.$125
  • Boehringer Ingelheim$103
  • Progenics Pharmaceuticals, Inc.$48
  • Bracco Diagnostics Inc.$16
  • Life Molecular Imaging Ltd$12
$16,000in research payments, 2019–2025

Across 1 payment — averaging $16,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Otsuka Pharmaceutical Development & Commercialization, Inc.$16K

What the payments were for

  • Food & beverage$303100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$303 in reported general payments places this provider in the 80th percentile of 893 diagnostic radiology providers in New Jersey.

See all diagnostic radiology providers in New Jersey

Medicare billing

Part B allowed, 2024
$871,250
Medicare patients
1,884
Services billed
68,309

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other diagnostic radiology in Toms River

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →